Biosynex SA (ALBIO.PA)

EUR 1.35

(-12.65%)

Total Liabilities Summary of Biosynex SA

Biosynex SA's latest annual total liabilities in 2023 was 117.41 Million EUR , up 25.96% from previous year.
Biosynex SA's latest quarterly total liabilities in 2023 FY was 117.41 Million EUR , up 25.96% from previous quarter.
Biosynex SA reported annual total liabilities of 93.21 Million EUR in 2022, down -7.84% from previous year.
Biosynex SA reported annual total liabilities of 101.13 Million EUR in 2021, up 69.17% from previous year.
Biosynex SA reported quarterly total liabilities of 129.4 Million EUR for 2023 Q2, down 0.0% from previous quarter.
Biosynex SA reported quarterly total liabilities of 117.41 Million EUR for 2023 FY, up 25.96% from previous quarter.

Annual Total Liabilities Chart of Biosynex SA (2023 - 2009)

Historical Annual Total Liabilities of Biosynex SA (2023 - 2009)

Year	Total Liabilities	Total Liabilities Growth
2023	117.41 Million EUR	25.96%
2022	93.21 Million EUR	-7.84%
2021	101.13 Million EUR	69.17%
2020	59.78 Million EUR	252.37%
2019	16.96 Million EUR	66.35%
2018	10.19 Million EUR	-12.1%
2017	11.6 Million EUR	-23.39%
2016	15.14 Million EUR	122.01%
2015	6.82 Million EUR	103.94%
2014	3.34 Million EUR	-0.24%
2013	3.35 Million EUR	-8.63%
2012	3.66 Million EUR	297.02%
2011	924.34 Thousand EUR	-1.96%
2010	942.86 Thousand EUR	-2.39%
2009	965.95 Thousand EUR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2023 Q4	117.41 Million EUR	0.0%
2023 Q2	129.4 Million EUR	0.0%
2023 FY	117.41 Million EUR	25.96%
2022 Q4	93.21 Million EUR	0.0%
2022 FY	93.21 Million EUR	-7.84%
2022 Q2	73.61 Million EUR	0.0%
2021 Q4	101.13 Million EUR	0.0%
2021 Q2	121.5 Million EUR	0.0%
2021 FY	101.13 Million EUR	69.17%
2020 Q2	28.62 Million EUR	0.0%
2020 Q4	59.78 Million EUR	0.0%
2020 FY	59.78 Million EUR	252.37%
2019 Q2	10.44 Million EUR	0.0%
2019 FY	16.96 Million EUR	66.35%
2019 Q4	16.96 Million EUR	0.0%
2018 Q4	10.19 Million EUR	0.0%
2018 FY	10.19 Million EUR	-12.1%
2018 Q2	10.49 Million EUR	0.0%
2017 FY	11.6 Million EUR	-23.39%
2017 Q2	14.62 Million EUR	0.0%
2017 Q4	11.6 Million EUR	0.0%
2016 FY	15.14 Million EUR	122.01%
2016 Q2	6.15 Million EUR	0.0%
2016 Q4	15.14 Million EUR	0.0%
2015 Q2	7.18 Million EUR	0.0%
2015 FY	6.82 Million EUR	103.94%
2015 Q4	6.82 Million EUR	0.0%
2014 Q4	3.34 Million EUR	0.0%
2014 FY	3.34 Million EUR	-0.24%
2014 Q2	4.12 Million EUR	0.0%
2013 Q2	3.26 Million EUR	0.0%
2013 FY	3.35 Million EUR	-8.63%
2013 Q4	3.35 Million EUR	0.0%
2012 Q4	3.66 Million EUR	0.0%
2012 Q2	3.3 Million EUR	0.0%
2012 FY	3.66 Million EUR	297.02%
2011 FY	924.34 Thousand EUR	-1.96%
2011 Q4	924.34 Thousand EUR	0.0%
2011 Q2	870.64 Thousand EUR	0.0%
2010 FY	942.86 Thousand EUR	-2.39%
2010 Q4	942.86 Thousand EUR	0.0%
2009 FY	965.95 Thousand EUR	0.0%

Peer Total Liabilities Comparison of Biosynex SA

Name	Total Liabilities	Total Liabilities Difference
Predilife S.A.	8.3 Million EUR	-1313.783%
bioMérieux S.A.	1.5 Billion EUR	92.209%
Eurofins Scientific SE	6.75 Billion EUR	98.261%
Lumibird SA	207.98 Million EUR	43.546%